Jason Krikorian - 13 Jul 2023 Form 4 Insider Report for Augmedix, Inc.

Role
Director
Signature
/s/ Paul Ginocchio, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
13 Jul 2023
Net transactions value
$0
Form type
4
Filing time
17 Jul 2023, 17:34:26 UTC
Previous filing
29 Jun 2023
Next filing
22 Aug 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AUGX Restricted Stock Units Award $0 +21,598 $0.000000 21,598 13 Jul 2023 Common Stock 21,598 $4.63 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Restricted Stock Unit ("RSU") is granted under the Augmedix, Inc. (the "Issuer") 2020 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock.
F2 The RSU will vest in full on the one-year anniversary of July 13, 2023, so long as the Reporting Person remains a director on such date.